ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag breast cancer culture disease medicine

Infusion of Artificial Intelligence in Biology
Meenakshi Prabhune, PhD | Feb 23, 2024 | 10 min read
With deep learning methods revolutionizing life sciences, researchers bet on de novo proteins and cell mapping models to deliver customized precision medicines.
Carolyn Bertozzi working in the laboratory with postdoctoral scholar Ula Gerling-Driessen
Trimming Undruggable Cancer Targets
Deanna MacNeil, PhD | Sep 13, 2023 | 4 min read
Researchers took aim at mucins, glycoproteins that protect cancer cells from drugs and the immune response, and engineered a revolutionary targeted tool for oncology and beyond.
MMTV and Breast Cancer
Douglas Steinberg | Apr 16, 2000 | 7 min read
Virus-Disease Links Are Hard to Forge Researchers confront skepticism, conflicting results, limited funding By Douglas Steinberg If genomics is glitzy nowadays, virus research is, well, gritty. Its latest heyday, when HIV was shown to cause AIDS, only masked its true nature. Associating viruses with diseases has always been particularly difficult and labor intensive. Cause-and-effect relationships are maddeningly elusive.1 Consider the following two questions: Does infection by mouse mammary
Image of pancreatic organoids under a microscope with immunofluorescent staining
Pancreatic Organoids Take the Stage
Laura Tran, PhD | Dec 1, 2023 | 2 min read
Meritxell Huch tackled her pipedream of growing three-dimensional pancreatic tissue in a dish.
Composite image showing genes radiating from tumor cells
Jumping Genes’ Role in Cancer
Diana Kwon | Mar 1, 2023 | 8 min read
Transposons may be key players in how tumors develop and spread, but they also keep cancer at bay in some circumstances.
Herceptin Earns Recognition in Breast Cancer Arsenal
Ricki Lewis | Apr 29, 2001 | 7 min read
With true success stories in cancer treatment so rare, the flood of recent papers validating the 1998 Food and Drug Administration approval of Herceptin (trastuzumab) stands out.1-3 In a broader sense, the drug's rocky road from conception to clinic also validates the concept of rational drug design, an approach that will become more common as pharmaceutical companies mine human genome information. "It is extremely gratifying to have gone though the first laboratory determinations, to clinical
Is Medicine Ready for Clinical CRISPR?
John Parrington | Dec 1, 2016 | 3 min read
Using precision genome editing to treat or prevent human disease may require several leaps of faith.
Organoid Culture Handbook
AMSbio | Oct 19, 2016 | 2 min read
AMSBIO announces an extended and updated edition of its popular Organoid Culture Handbook
New Understanding of Metastasis Could Lead to Better Treatments
Shawna Williams | Apr 1, 2021 | 10+ min read
Recent insights, such as the recognition that disseminated cancer cells can lie dormant for years before seeding secondary tumors, suggest novel strategies for fighting metastatic disease.
multicolor DNA sequencing gel
Genetic Mutations Can Be Benign or Cancerous—a New Method to Differentiate Between Them Could Lead to Better Treatments
Ryan Layer, The Conversation | May 27, 2022 | 5 min read
Tumors contain thousands of genetic changes, but only a few are actually cancer-causing. A quicker way to identify these driver mutations could lead to more targeted cancer treatments.

Run a Search

ADVERTISEMENT